Antitubercular and antimicrobial activity of nh4vo3 promoted 1,4-dihydropyridine incorporated 1,3,4-Trisubstituted pyrazole

dc.contributor.authorHarikrishna, N.
dc.contributor.authorIsloor, A.M.
dc.contributor.authorKulal, K.
dc.contributor.authorParish, T.
dc.contributor.authorJamalis, J.
dc.contributor.authorGhabbour, H.A.
dc.contributor.authorFun, H.-K.
dc.date.accessioned2026-02-05T09:32:38Z
dc.date.issued2017
dc.description.abstractBackground: A new series of pyrazole containing 1,4-dihydropyridine derivatives 5a-i and 6a-i were synthesized from substituted acetylated aryls and substituted phenylhydrazine by the multistep reaction. Method: The target compounds 1,4-dihydropyridine derivatives were obtained from green synthesis of 1,3-disubstituted phenyl-1H-pyrazole-4-carbaldehydes 4a-i with ethyl acetoacetate and methyl acetoacetate at higher temperatures in the presence of ammonium acetate and the catalytic amount of ammonium metavanadate (NH4VO3). The role of ammonium metavanadate was increases rate of the reaction and obtained high yields. Result: Structures of newly synthesized 1,4-dihydropyridine moiety containing pyrazole derivatives were confirmed by FT-IR, NMR and Mass spectral studies. The structure of compound 5b was confirmed by S-XRD study. Further, these compounds were tested for in-vitro antitubercular and antimicrobial studies. Compounds 5a, 5b, 5i, 6a, 6b, 6g, 6h, and 6i were found to be active against all the bacterial microorganisms. Conclusion: The above mentioned compounds have shown lowest MIC ranging between 3.12-12.5 ?g/ml against Mycobacterium tuberculosis and MIC values ranging between 7.8- 15.6 ?g/ml for Mycobacterium smegmatis, Staphylococcus aureus and Pseudomonas aeruginosa. For the control of life threatening diseases such as tuberculosis, these eight compounds may be strongly promising synthetic compounds. © 2017 Bentham Science Publishers.
dc.identifier.citationLetters in Drug Design and Discovery, 2017, 14, 6, pp. 699-711
dc.identifier.issn15701808
dc.identifier.urihttps://doi.org/10.2174/1570180813666161103145224
dc.identifier.urihttps://idr.nitk.ac.in/handle/123456789/25764
dc.publisherBentham Science Publishers B.V. P.O. Box 294 Bussum 1400 AG
dc.subject1 phenyl 3 thiophen 2 yl 1h pyrazole 4 carbaldehyde
dc.subject1,4 dihydropyridine derivative
dc.subject2,6 dimethyl 4 (1 phenyl 3 thiophene 2 yl 1h pyrazol 4 yl) 2,6 dimethyl 1,4 dihydropyridine 3,5 dicarboxylicacid diethylester
dc.subject3 (3 bromophenyl) 1 (4 chlorophenyl) 1h pyrazole 4 carbaldehyde
dc.subject3 biphenyl 4 yl 1 (4 chlorophenyl) 1h pyrazole 4 carbaldehyde
dc.subject4 [1 (4 chlorophenyl) 3 (4 methoxyphenyl) 1h pyrazol 4 yl] 2,6 dimethyl 1,4 dihydropyridine 3,5 dicarboxylicacid diethylester
dc.subject4 [1 (4 chlorophenyl) 3 (4 methoxyphenyl) 1h pyrazol 4 yl] 2,6 dimethyl 1,4 dihydropyridine 3,5 dicarboxylicacid dimethylester
dc.subject4 [1 (4 chlorophenyl) 3 para tolyl 1h pyrazol 4 yl] 2,6 dimethyl 1,4 dihydropyridine 3,5 dicarboxylicacid diethylester
dc.subject4 [1 (4 chlorophenyl) 3 para tolyl 1h pyrazol 4 yl] 2,6 dimethyl 1,4 dihydropyridine 3,5 dicarboxylicacid dimethylester
dc.subject4 [1 (4 chlorophenyl) 3 thiophene 2 yl 1h pyrazol 4 yl] 2,6 dimethyl 1,4 dihydropyridine 3,5 dicarboxylicacid diethylester
dc.subject4 [1 (4 chlorophenyl) 3 thiophene 2 yl 1h pyrazol 4 yl] 2,6 dimethyl 1,4 dihydropyridine 3,5 dicarboxylicacid dimethylester
dc.subject4 [1,3 bis(4 chlorophenyl) 1h pyrazol 4 yl] 2,6 dimethyl 1,4 dihydropyridine 3,5 dicarboxylicacid diethylester
dc.subject4 [1,3 bis(4 chlorophenyl) 1h pyrazol 4 yl] 2,6 dimethyl 1,4 dihydropyridine 3,5 dicarboxylicacid dimethylester
dc.subject4 [3 (3 bromophenyl) 1 (4 chlorophenyl) 1h pyrazol 4 yl] 2,6 dimethyl 1,4 dihydropyridine 3,5 dicarboxylicacid diethylester
dc.subject4 [3 (3 bromophenyl) 1 (4 chlorophenyl) 1h pyrazol 4 yl] 2,6 dimethyl 1,4 dihydropyridine 3,5 dicarboxylicacid dimethylester
dc.subject4 [3 (3 bromophenyl) 1 phenyl 1h pyrazol 4 yl] 2,6 dimethyl 1,4 dihydropyridine 3,5 dicarboxylicacid diethylester
dc.subject4 [3 (3 bromophenyl) 1 phenyl 1h pyrazol 4 yl] 2,6 dimethyl 1,4 dihydropyridine 3,5 dicarboxylicacid dimethylester
dc.subject4 [3 (4 bromophenyl) 1 (4 chlorophenyl) 1h pyrazol 4 yl] 2,6 dimethyl 1,4 dihydropyridine 3,5 dicarboxylicacid diethylester
dc.subject4 [3 (4 bromophenyl) 1 (4 chlorophenyl) 1h pyrazol 4 yl] 2,6 dimethyl 1,4 dihydropyridine 3,5 dicarboxylicacid dimethylester
dc.subject4 [3 biphenyl 4 yl 1 (4 chlorophenyl) 1h pyrazol 4 yl] 2,6 dimethyl 1,4 dihydropyridine 3,5 dicarboxylicacid dimethylester
dc.subjectammonium vanadate
dc.subjectantibiotic agent
dc.subjectantifungal agent
dc.subjectciprofloxacin
dc.subjectethambutol
dc.subjectfluconazole
dc.subjectpyrazinamide
dc.subjectpyrazole derivative
dc.subjectstreptomycin
dc.subjecttuberculostatic agent
dc.subjectunclassified drug
dc.subjectantibacterial activity
dc.subjectantifungal activity
dc.subjectantitubercular activity
dc.subjectArticle
dc.subjectCandida albicans
dc.subjectcarbon nuclear magnetic resonance
dc.subjectcontrolled study
dc.subjectcrystal structure
dc.subjectdrug activity
dc.subjectdrug efficacy
dc.subjectdrug mechanism
dc.subjectdrug synthesis
dc.subjectdrug targeting
dc.subjectgreen chemistry
dc.subjecthigh temperature
dc.subjectin vitro study
dc.subjectinfrared spectroscopy
dc.subjectinhibition zone
dc.subjectmass spectrometry
dc.subjectminimum inhibitory concentration
dc.subjectMycobacterium smegmatis
dc.subjectMycobacterium tuberculosis
dc.subjectnonhuman
dc.subjectpriority journal
dc.subjectproton nuclear magnetic resonance
dc.subjectPseudomonas aeruginosa
dc.subjectreaction analysis
dc.subjectStaphylococcus aureus
dc.subjectstructure activity relation
dc.subjectsubstitution reaction
dc.subjectX ray diffraction
dc.titleAntitubercular and antimicrobial activity of nh4vo3 promoted 1,4-dihydropyridine incorporated 1,3,4-Trisubstituted pyrazole

Files

Collections